LINE-1 methylation status has been identified as a therapeutic marker, associated with the prognosis of patients undergoing oral fluoropyrimidine therapy for stage II or III CRC.462 Further studies have highlighted the role of DNA methylation in influencing the behavior of bystander CD8+ TILs. Here, CD8A is linked to colorectal carcinoma.